Veriheal

JANUARY 26, 2023

Most commonly, pharmaceutical medication is prescribed to regulate moods. However, pharmaceutical medications can have side effects, and they may take longer to work for many patients. Thus, this groundbreaking study laid the foundation for understanding how cannabinoids can support mental health.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs.

Data 89

Data Chronic Pain Sleep Patients 89

Veriheal

OCTOBER 3, 2022

With the growing acceptance and legalization of cannabis, the pharmaceutical industry is taking serious hits, according to a 2022 novel study into the impact of cannabis legalization on pharmaceutical firms. What Is the Pharmaceutical Industry? pharmaceuticals). Still, most pharmaceuticals are heavily processed.

Pharmaceutical 104

Pharmaceutical Patients Research and Development Legalization 104

The Joint Blog

NOVEMBER 2, 2020

According to a new study published in the Journal of Pharmacy & Pharmaceutical Sciences, using marijuana as an adjunct treatment for Huntington disease (HD) is both effective and safe. The study states that marijuana can improve neurological symptoms and should be recommended to HD patients by their physicians.

Treatment 37

Treatment Sleep Marijuana Patients 37

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

SEPTEMBER 14, 2021

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

AUGUST 16, 2021

It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child.

Safety 116

Safety Patients Cannabis Law 116

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

In reality, people using marijuana during this time may have been self-medicating for a mental condition, choosing to use a different coping mechanism than the pharmaceuticals available at the time, pursuing better sleep, or simply enjoying a nontraditional method of increasing productivity and creativity. Eades, J., & Hogue, O.

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Canna Care Docs

JULY 29, 2019

It makes me relax, which in turn slows the shaking down and I can grab some sleep,” she said. Noting her mother’s reduced pain and relief from other pharmaceutical side effects, she said, “I have to say, I’m kind of an advocate for it.” I’m grateful to see her not take those opioids so much,” Ms. Edelstein said. Gluchacki said.

Chronic Pain 53

Chronic Pain Sleep Education Dispensary 53

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Many people use CBD to help them sleep, relieve anxiety, or both. Sonya Yruel/Drug Policy Alliance).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Info

MARCH 2, 2019

Epilepsy is usually diagnosed after patients have experienced a series of seizures. However, the most common attempt at treating the condition is through medication, many patients may need to take them for the rest of their life. ” CBD may be easier for patients to access when they opt to start treatment with medical cannabis.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

CannaTech

OCTOBER 14, 2018

billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. Similarly, many sleepless sufferers claim that such products have allowed them to rest more peacefully as they are able to sleep better and longer. In the U.S. One of the best examples is a recent study that led to the U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Veriheal

SEPTEMBER 23, 2021

Once sleep comes, the guests will wake up the next day and feel a lightness, clarity, and focus that they haven’t felt in a long time. The team also reaches out to previous patients several times throughout the year to check-in. Many people should expect to be awake for at least 24 hours. Main Takeaway.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. Epilepsy Behav.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. No doctor is going to say to a patient ‘smoke two joints and call me in the morning’,” he said.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

SpeedWeed

JULY 8, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”. I think in the U.S.,

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

SpeedWeed

JULY 8, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”. I think in the U.S.,

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

SpeedWeed

JULY 7, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”. I think in the U.S.,

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

SpeedWeed

JULY 7, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”. I think in the U.S.,

Research and Development 52

Research and Development Pharmaceutical Cannabinoids Supply Chain 52

SpeedWeed

JULY 6, 2021

Clever Leaves , a cultivator, manufacturer and distributor listed on the Nasdaq, announced its entrance into Mexico last month with an active pharmaceutical ingredient (API) supply agreement with CBD Life, beginning with cannabidiol (CBD) isolate. A lot of these countries are just beginning their cannabinoid journey.”. I think in the U.S.,

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. The states’ situation varies substantially.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

NOVEMBER 23, 2021

And for the most part, patients are undertaking this journey alone and often with little guidance. There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. Tell us a bit more about the interview, what did you two talk about?

Data 52

Data Patients Access Wellness and Beauty 52

The Cannigma

FEBRUARY 3, 2022

of babies, to doing robotic surgery, and now, helping geriatric patients navigate cannabis medicine. It is a challenging landscape to navigate and Dr. Bone is just doing phenomenal work helping patients. That’s always the struggle we have when people want data and research and medical research to establish exactly how something works.

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

CannaTech

FEBRUARY 25, 2019

Each of the country’s Ministry of Health approved cannabis farms and production facilities have developed proprietary medical products, contributing to the global ecosystem and offering relief to patients. Indorz : Indoor cannabis farming data solution that predicts, analyzes, and automates the grow process to maximize yield and quality.

Research and Development 85

Research and Development Hybrid Treatment Strains 85

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Highlights: According to a U.S. The patent.

THC 64

THC CBD Cannabinoids Research and Development 64

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Obviously, that means that there are more patients and there are more products to sell. You can open up the market for them.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Green Relief

MAY 12, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Highlights: According to a U.S. The patent.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

OCTOBER 12, 2021

Diamandis joins Radicle Science as the healthtech company accelerates growth with industry veteran Sheldon Borkin PhD as CTO, the launch of a first of its kind real-world sleep study, and updates on significant milestones this year. Radicle Real World Sleep results will be announced in early 2022. “We

Clinical Trials 52

Clinical Trials Research and Development Sleep Cannabinoids 52

Cannabis Law Report

DECEMBER 7, 2021

The four-week Institutional Review Board (IRB) approved randomized controlled trial (RCT) of nearly 3,000 participants assigned to different botanical products containing CBD revealed significant improvement across all five health outcomes studied: well-being, quality of life, longer-term pain, feelings of anxiety, and sleep quality.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. Well, partners, of course on the cannabis enigma, yeah, let’s listen to Nikki.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

AUGUST 24, 2019

Patients, physicians, and the public all want to learn more about medical marijuana. In addition to banking obstacles in the cannabis business, there is a long trail ahead before there is unfettered banking access for cannabis patients. Leafly partnered with Whitney Economics , an Oregon firm to compile these statistics.

Banking 49

Banking Marijuana Media Patients 49

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Jonathan is the CEO and founder of Gilgamesh Pharmaceuticals. Lucia started her career advising pharmaceutical companies in investment banking. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. The latter formed the ‘medical user’ group.

Cannabis 45

Cannabis Access Patients Legalization 45

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . In light of all this state cannabis information overload, what are some of the reasons a patient ultimately chooses a qualified personal cannabis physician? .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

MAY 14, 2022

Based upon the significant public concern for safety and lack of scientific and public health data related to the conversion process, the state’s Cannabis Regulatory Agency withdrew the proposed rulemaking. MI – Michigan cannabis regulators axed a plan to allow hemp to be synthetically converted to THC.

Banking 52

Banking Recreational Research and Development Cannabis 52